Market Cap for Incyte (INCY)
According to Incyte's latest reported financial statements, the company's latest reported market cap is $19.47B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
INCY
Currently viewingMarket CapSwitch metric
Latest period
$19.47B
YoY change
+3.4%
5Y CAGR
+4.7%
Peak year (2026)
$20.50B
Latest annual
$20.50B
Market Cap history chart for Incyte (INCY) from 1993 to 2026
Market Cap history table for Incyte (INCY) from 1993 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $20.50B | +3.4% | ||
| 2025 | $19.82B | +36.3% | ||
| 2024 | $14.54B | +2.5% | ||
| 2023 | $14.19B | -21.1% | ||
| 2022 | $17.99B | +10.4% | ||
| 2021 | $16.30B | -14.1% | ||
| 2020 | $18.97B | -0.2% | ||
| 2019 | $19.01B | +38.6% | ||
| 2018 | $13.71B | -29.2% | ||
| 2017 | $19.38B | -0.5% | ||
| 2016 | $19.46B | -4.2% | ||
| 2015 | $20.31B | +65.4% | ||
| 2014 | $12.28B | +63.4% | ||
| 2013 | $7.51B | +248.6% | ||
| 2012 | $2.16B | +14.5% | ||
| 2011 | $1.88B | -6.6% | ||
| 2010 | $2.01B | +114.8% | ||
| 2009 | $937.81M | +175.6% | ||
| 2008 | $340.29M | -59.8% | ||
| 2007 | $846.06M | +72.9% | ||
| 2006 | $489.39M | +10.0% | ||
| 2005 | $444.93M | -40.3% | ||
| 2004 | $744.80M | +52.6% | ||
| 2003 | $488.16M | +58.8% | ||
| 2002 | $307.36M | -76.1% | ||
| 2001 | $1.29B | -18.2% | ||
| 2000 | $1.57B | -6.9% | ||
| 1999 | $1.69B | +56.3% | ||
| 1998 | $1.08B | -9.6% | ||
| 1997 | $1.19B | +131.9% | ||
| 1996 | $515.00M | +149.7% | ||
| 1995 | $206.25M | +112.0% | ||
| 1994 | $97.29M | +69.0% | ||
| 1993 | $57.56M | — |
Market Cap values are taken from Incyte's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2026's annual market cap for Incyte (INCY) came in at $20.50B – edged up 3.4% year-over-year.
Through 2021–2026 (5 years), Incyte market cap delivered a +4.7% annualised rate; sustaining 3 straight years of year-over-year growth.
$20.50B stands as the all-time-high annual market cap, posted in 2026, against a low of $57.56M during 1993.
Among 8 Healthcare peers, Incyte (INCY) ranks 9th; the peer median for market cap is $311.16B.
Incyte Market Cap by Year
Incyte Market Cap 2026: $20.50B
Incyte market cap in 2026 was $20.50B, edged up 3.4% from 2025. This figure represents the highest annual value in the available history.
Incyte Market Cap 2025: $19.82B
Incyte market cap in 2025 was $19.82B, surged 36.3% from 2024.
Incyte Market Cap 2024: $14.54B
Incyte market cap in 2024 was $14.54B, edged up 2.5% from 2023.
Incyte Market Cap 2023: $14.19B
Incyte market cap in 2023 was $14.19B, declined 21.1% below 2022.
Incyte Market Cap 2022: $17.99B
Incyte market cap in 2022 was $17.99B.
See more financial history for Incyte (INCY).
Sector peers — Market Cap
Companies in the same sector as Incyte, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Incyte's market cap?
- Latest reported market cap for Incyte (INCY) is $19.47B (period ending March 31, 2026).
How has Incyte market cap changed year-over-year?
- Incyte (INCY) market cap changed +3.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Incyte market cap?
- Incyte (INCY) market cap compound annual growth rate is +4.7% over the most recent 5 years available.
When did Incyte market cap hit its highest annual value?
- Incyte market cap reached its highest annual value of $20.50B in 2026.
What was Incyte market cap in 2025?
- Incyte (INCY) market cap in 2025 was $19.82B.
What was Incyte market cap in 2026?
- Incyte (INCY) market cap in 2026 was $20.50B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INCY Overview
Company profile, financial tools, and key metrics
INCY Revenue Counter
Earns $163.03 every second. See per minute, hour, and day.
INCY Earnings Counter
Earns $40.80 per second net profit. See per minute, hour, and day.
INCY Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
INCY What If Invested
What if you had invested $1,000? See historical returns from any date.
INCY How It Makes Money
Discover visual breakdown of $5.14B in revenue — where it comes from and where it goes.
INCY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INCY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INCY Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
INCY Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
INCY Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.